Plasma carbonyls do not correlate with lung function or computed tomography measures of lung density in older smokers

Sonia Mesia-Vela, Chih Ching Yeh, John Austin, Matthew Dounel, Charles Powell, Anthony Reeves, Regina M. Santella, Lori Stevenson, David Yankelevitz, R. Graham Barr

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Oxidative stress and inflammation are hallmarks of chronic obstructive pulmonary disease (COPD). A critical byproduct of oxidative damage is the introduction of carbonyl groups into amino acid residues. We hypothesize that plasma carbonyl content is inversely correlated with lung function and computed tomography (CT) measures of lung density among smokers and is elevated in COPD. Carbonyl was measured in plasma of participants aged 60 years and older by ELISA. Generalized linear and additive models were used to adjust for potential confounders. Among 541 participants (52% male, mean age 67 years, 41% current smokers), mean plasma carbonyl content was 17.9 ± 2.9 nmol ml-1 and mean forced expiratory volume in one second (FEV1) was 80.7 ± 20.9% of predicted. Plasma carbonyl content was inversely associated with FEV1, but this relationship was largely explained by age. Multivariate analyses ruled out clinically meaningful associations of plasma carbonyl content with FEV1, FEV1/FVC (forced vital capacity) ratio, severity of airflow obstruction, and CT lung density. Plasma carbonyl content is a poor biomarker of oxidative stress in COPD and emphysema.

Original languageEnglish
Pages (from-to)422-434
Number of pages13
JournalBiomarkers
Volume13
Issue number4
DOIs
Publication statusPublished - Jun 2008
Externally publishedYes

Fingerprint

Tomography
Plasmas
Lung
Pulmonary diseases
Chronic Obstructive Pulmonary Disease
Oxidative stress
Oxidative Stress
Pulmonary Emphysema
Vital Capacity
Forced Expiratory Volume
Biomarkers
Byproducts
Linear Models
Multivariate Analysis
Enzyme-Linked Immunosorbent Assay
Inflammation
Amino Acids

Keywords

  • Airflow obstruction
  • COPD
  • CT
  • EMCAP
  • Oxidative stress
  • Protein carbonyl
  • Pulmonary emphysema
  • Smoking

ASJC Scopus subject areas

  • Biotechnology
  • Toxicology

Cite this

Plasma carbonyls do not correlate with lung function or computed tomography measures of lung density in older smokers. / Mesia-Vela, Sonia; Yeh, Chih Ching; Austin, John; Dounel, Matthew; Powell, Charles; Reeves, Anthony; Santella, Regina M.; Stevenson, Lori; Yankelevitz, David; Graham Barr, R.

In: Biomarkers, Vol. 13, No. 4, 06.2008, p. 422-434.

Research output: Contribution to journalArticle

Mesia-Vela, S, Yeh, CC, Austin, J, Dounel, M, Powell, C, Reeves, A, Santella, RM, Stevenson, L, Yankelevitz, D & Graham Barr, R 2008, 'Plasma carbonyls do not correlate with lung function or computed tomography measures of lung density in older smokers', Biomarkers, vol. 13, no. 4, pp. 422-434. https://doi.org/10.1080/13547500802002859
Mesia-Vela, Sonia ; Yeh, Chih Ching ; Austin, John ; Dounel, Matthew ; Powell, Charles ; Reeves, Anthony ; Santella, Regina M. ; Stevenson, Lori ; Yankelevitz, David ; Graham Barr, R. / Plasma carbonyls do not correlate with lung function or computed tomography measures of lung density in older smokers. In: Biomarkers. 2008 ; Vol. 13, No. 4. pp. 422-434.
@article{8a229369f21042b7ba35bbce4775998d,
title = "Plasma carbonyls do not correlate with lung function or computed tomography measures of lung density in older smokers",
abstract = "Oxidative stress and inflammation are hallmarks of chronic obstructive pulmonary disease (COPD). A critical byproduct of oxidative damage is the introduction of carbonyl groups into amino acid residues. We hypothesize that plasma carbonyl content is inversely correlated with lung function and computed tomography (CT) measures of lung density among smokers and is elevated in COPD. Carbonyl was measured in plasma of participants aged 60 years and older by ELISA. Generalized linear and additive models were used to adjust for potential confounders. Among 541 participants (52{\%} male, mean age 67 years, 41{\%} current smokers), mean plasma carbonyl content was 17.9 ± 2.9 nmol ml-1 and mean forced expiratory volume in one second (FEV1) was 80.7 ± 20.9{\%} of predicted. Plasma carbonyl content was inversely associated with FEV1, but this relationship was largely explained by age. Multivariate analyses ruled out clinically meaningful associations of plasma carbonyl content with FEV1, FEV1/FVC (forced vital capacity) ratio, severity of airflow obstruction, and CT lung density. Plasma carbonyl content is a poor biomarker of oxidative stress in COPD and emphysema.",
keywords = "Airflow obstruction, COPD, CT, EMCAP, Oxidative stress, Protein carbonyl, Pulmonary emphysema, Smoking",
author = "Sonia Mesia-Vela and Yeh, {Chih Ching} and John Austin and Matthew Dounel and Charles Powell and Anthony Reeves and Santella, {Regina M.} and Lori Stevenson and David Yankelevitz and {Graham Barr}, R.",
year = "2008",
month = "6",
doi = "10.1080/13547500802002859",
language = "English",
volume = "13",
pages = "422--434",
journal = "Biomarkers",
issn = "1354-750X",
publisher = "Informa Healthcare",
number = "4",

}

TY - JOUR

T1 - Plasma carbonyls do not correlate with lung function or computed tomography measures of lung density in older smokers

AU - Mesia-Vela, Sonia

AU - Yeh, Chih Ching

AU - Austin, John

AU - Dounel, Matthew

AU - Powell, Charles

AU - Reeves, Anthony

AU - Santella, Regina M.

AU - Stevenson, Lori

AU - Yankelevitz, David

AU - Graham Barr, R.

PY - 2008/6

Y1 - 2008/6

N2 - Oxidative stress and inflammation are hallmarks of chronic obstructive pulmonary disease (COPD). A critical byproduct of oxidative damage is the introduction of carbonyl groups into amino acid residues. We hypothesize that plasma carbonyl content is inversely correlated with lung function and computed tomography (CT) measures of lung density among smokers and is elevated in COPD. Carbonyl was measured in plasma of participants aged 60 years and older by ELISA. Generalized linear and additive models were used to adjust for potential confounders. Among 541 participants (52% male, mean age 67 years, 41% current smokers), mean plasma carbonyl content was 17.9 ± 2.9 nmol ml-1 and mean forced expiratory volume in one second (FEV1) was 80.7 ± 20.9% of predicted. Plasma carbonyl content was inversely associated with FEV1, but this relationship was largely explained by age. Multivariate analyses ruled out clinically meaningful associations of plasma carbonyl content with FEV1, FEV1/FVC (forced vital capacity) ratio, severity of airflow obstruction, and CT lung density. Plasma carbonyl content is a poor biomarker of oxidative stress in COPD and emphysema.

AB - Oxidative stress and inflammation are hallmarks of chronic obstructive pulmonary disease (COPD). A critical byproduct of oxidative damage is the introduction of carbonyl groups into amino acid residues. We hypothesize that plasma carbonyl content is inversely correlated with lung function and computed tomography (CT) measures of lung density among smokers and is elevated in COPD. Carbonyl was measured in plasma of participants aged 60 years and older by ELISA. Generalized linear and additive models were used to adjust for potential confounders. Among 541 participants (52% male, mean age 67 years, 41% current smokers), mean plasma carbonyl content was 17.9 ± 2.9 nmol ml-1 and mean forced expiratory volume in one second (FEV1) was 80.7 ± 20.9% of predicted. Plasma carbonyl content was inversely associated with FEV1, but this relationship was largely explained by age. Multivariate analyses ruled out clinically meaningful associations of plasma carbonyl content with FEV1, FEV1/FVC (forced vital capacity) ratio, severity of airflow obstruction, and CT lung density. Plasma carbonyl content is a poor biomarker of oxidative stress in COPD and emphysema.

KW - Airflow obstruction

KW - COPD

KW - CT

KW - EMCAP

KW - Oxidative stress

KW - Protein carbonyl

KW - Pulmonary emphysema

KW - Smoking

UR - http://www.scopus.com/inward/record.url?scp=45749118767&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=45749118767&partnerID=8YFLogxK

U2 - 10.1080/13547500802002859

DO - 10.1080/13547500802002859

M3 - Article

C2 - 18484356

AN - SCOPUS:45749118767

VL - 13

SP - 422

EP - 434

JO - Biomarkers

JF - Biomarkers

SN - 1354-750X

IS - 4

ER -